or Try an Advanced Search...

    Technical Analysis for DYN - Dyne Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 29.38 4.33% 1.22
    DYN closed up 4.33 percent on Wednesday, May 15, 2024, on 85 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical DYN trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing High Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Stochastic Reached Overbought Strength 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Above Upper BB Strength 0.00%
    Gapped Up Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    Up 5 Days in a Row Strength 0.00%
    Older End-of-Day Signals for DYN ...

       Recent Intraday Alerts

    Alert Time
    Possible Pocket Pivot about 18 hours ago
    Up 1 ATR about 18 hours ago
    60 Minute Opening Range Breakout about 18 hours ago
    Up 5% about 20 hours ago
    Bullish 180 Entry about 20 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    DYN Chart by TradingView
    Basic chart:

    Profile

    Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The Company utilizes its proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery with modern oligonucleotide therapeutic candidates. Dyne is developing a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD).
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Oligonucleotide Duchenne Muscular Dystrophy Duchenne Myotonic Dystrophy Genetic Genealogy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases

    Is DYN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 4 We're Hopeful That Dyne Therapeutics (NASDAQ:DYN) Will Use Its Cash Wisely
    May 4 Dyne Therapeutics Inc (DYN) Q1 2024 Earnings: Aligns with Analyst Projections
    May 3 Dyne Therapeutics GAAP EPS of -$0.81 misses by $0.01
    May 2 Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
    Mar 27 Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer
    Mar 27 Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
    Mar 25 Dyne Therapeutics appoints John Cox CEO
    Mar 25 Dyne Therapeutics Announces CEO Transition
    Mar 13 Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
    Mar 7 Dyne Therapeutics Inc (DYN) Reports Encouraging Clinical Data and Financial Growth for Q4 and ...
    See more DYN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 30.2687
    52 Week Low 6.4
    Average Volume 1,190,967
    200-Day Moving Average 16.55
    50-Day Moving Average 26.45
    20-Day Moving Average 25.68
    10-Day Moving Average 26.58
    Average True Range 1.53
    RSI (14) 69.04
    ADX 12.7
    +DI 30.57
    -DI 16.85
    Chandelier Exit (Long, 3 ATRs) 25.30
    Chandelier Exit (Short, 3 ATRs) 27.69
    Upper Bollinger Bands 28.33
    Lower Bollinger Band 23.03
    Percent B (%b) 1.2
    BandWidth 20.66
    MACD Line 0.48
    MACD Signal Line 0.08
    MACD Histogram 0.4015
    Fundamentals Value
    Market Cap 2.38 Billion
    Num Shares 81.1 Million
    EPS -3.59
    Price-to-Earnings (P/E) Ratio -8.18
    Price-to-Sales 0.00
    Price-to-Book 12.82
    PEG Ratio 0.19
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 31.63
    Resistance 3 (R3) 31.55 30.71 31.25
    Resistance 2 (R2) 30.71 30.14 30.75 31.13
    Resistance 1 (R1) 30.05 29.79 30.38 30.13 31.00
    Pivot Point 29.21 29.21 29.38 29.25 29.21
    Support 1 (S1) 28.55 28.64 28.88 28.63 27.76
    Support 2 (S2) 27.71 28.29 27.76 27.63
    Support 3 (S3) 27.05 27.71 27.51
    Support 4 (S4) 27.13